ASCO 2008: Single chemotherapy dose as effective as radiation for early testicular cancer
Thursday, 12 June 2008 - The first randomised trial to evaluate the long-term outcome of treatment with a single dose of chemotherapy for early-stage testicular tumours has concluded that the approach is safe, effective and less toxic compared to radiation therapy, the current standard of care.
The study, presented...
AUA 2008 - Use of imaging to expand in urologic surgery
Wednesday, 11 June 2008 - Use of imaging to expand in urologic surgeryIn his state-of-the-art lecture on “Advances in Imaging for Urologic Oncology” given during the Annual AUA Congress recently held in Orlando, Florida, Dr. Inderbir Gill underscored that imaging will play a much larger role in urologic surgery in the...
AUA 2008: PDE5 inhibitors as initial strategy after radical prostatectomy
Tuesday, 10 June 2008 - Although multifactorial, the occurrence of ED following radical prostatectomy may be amenable to several measures and PED5 inhibitors can be of value as an initial strategy. This was one of the messages of Prof. Franceso Montorsi in his SIU Lecture titled ‘PDE5 Inhibitors: A New Tool in...
AUA 2008 - Multiple gene variants linked to PCa risk
Monday, 9 June 2008 - Multiple gene variants are linked to an individual’s risk of developing prostate cancer (PCa) and these variants include single nucleotide polymorphisms (SNPs) in five chromosomal regions. This was described by Dr. Jianfeng Xu during the special late breaking session held at the Annual Congress...
AUA 2008: Novick, Kropp lead AUA awards
Thursday, 5 June 2008 - Andrew Novick’s seminal work in renovascular surgery of the kidney and Bradley Kropp’s trailblazing research in tissue engineering as it applies to paediatric urinary reconstruction garnered the American Urological Association (AUA) top honours given during the association’s recent annual...
ASCO 2008: Phase-III study shows RAD001 improves PFS in patients with mRCC
Saturday, 31 May 2008 - A Phase-III study showed that RAD0001 significantly improves progression-free survival (PFS) over placebo with a favourable safety profile in patients with metastatic renal cell carcinoma (mRCC) after progression on other targeted therapies.
In an abstract presented at the 44th...
AUA 2008: Oral ED therapy is challenged by Maxi-K gene transfer
Monday, 26 May 2008 - Maxi-K gene therapy may be a safe and effective future option for men whose erectile dysfunction (ED) is not treatable with oral therapy. Two studies presented at the 103rd Annual Scientific Meeting of the American Urological Association (AUA) may give hope to these individuals.
Maxi-K therapy...
AUA 2008: Former firefighters should be enrolled in routine screening for bladder cancer
Monday, 26 May 2008 - A new study presented at the Annual Scientific Meeting of the American Urological Association (AUA) suggests that firefighters may be at an increased risk of developing transitional cell carcinoma (TCC, or bladder cancer) and should be considered for routine annual screening. Currently, no...
AUA 2008: Muscle-derived stem cells repair spincter damage to restore continence
Saturday, 24 May 2008 - Transplantation of muscle-derived stem cells may provide a safe and effective treatment for patients suffering from urinary incontinence following a surgical procedure. Two studies presented at the 103rd Annual Scientific Meeting of the American Urological Association (AUA), show that patients...
AUA 2008: US researchers found vaccination therapy for metastatic prostate cancer
Saturday, 24 May 2008 - A new prostate cancer vaccine may give hope to men with metastatic prostate cancer by enabling their immune systems to fight the disease. Researchers from the University of Iowa presented data on the adenovirus/PSA (Ad/PSA) vaccine during the Annual Scientific Meeting of the American Urological...













